TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HEPATOCELLULAR CARCINOMA (HCC) WITH COMPOUNDS BINDING THE ECTODOMAIN OF PLATELET GLYCOPROTEIN IB (GPIB) ALPHA